Lung Cancers Completed Phase 1 / 2 Trials for Everolimus (DB01590)

Also known as: LUng Cancer / Cancer, Lung / Lung neoplasm malignant / Lung cancer NOS / Cancer of lung / Ca lung

DBCOND0072929 (Lung Cancers)Completed1 / 2 IdentifierTitlePurposeDrugs
NCT00096486Gefitinib and Everolimus in Treating Patients With Stage IIIB or Stage IV or Recurrent Non-Small Cell Lung CancerTreatment